Uri Yablonka, EVP & Chief Business Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 2,000 shares at $3.98 ($8K) on 2017-08-23, disclosed to the SEC on 2017-08-23.
Open-market purchase of $8k BCLI by EVP & Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.